Expression of cicScer\UAS.cLa under the control of Scer\GAL4cv-c-C5 results in a substantial reduction in wing veins, as compared to controls.
Expression of cicScer\UAS.cLa in the eye, driven by Scer\GAL4GMR.PF, causes mild ommatidial disorganization.
Expression of cicScer\UAS.cLa, under the control of Scer\GAL4C5, causes the loss of veins in the posterior part of the wing, including the posterior crossvein.
cicUAS.cLa, Scer\GAL4GMR.PF is a suppressor of visible phenotype of Hsap\ATXN182Q.UAS, Scer\GAL4GMR.PF
Scer\GAL4cv-c-C5, cicUAS.cLa has posterior crossvein phenotype, suppressible by Hsap\ATXN182Q.UAS, Scer\GAL4cv-c-C5
cicUAS.cLa is a suppressor of posterior crossvein phenotype of Hsap\ATXN182Q.UAS, Scer\GAL4cv-c-C5
cicUAS.cLa, Scer\GAL4GMR.PF is a suppressor of ommatidium phenotype of Hsap\ATXN182Q.UAS, Scer\GAL4GMR.PF
cicUAS.cLa, Scer\GAL4GMR.PF is a suppressor of interommatidial bristle phenotype of Hsap\ATXN182Q.UAS, Scer\GAL4GMR.PF
Coexpression of cicScer\UAS.cLa and Hsap\ATX182Q.Scer\UAS, both under the control of Scer\GAL4GMR.PF, results in a milder eye phenotype than expression of Hsap\ATX182Q.Scer\UAS alone; there is less ommatidial disorganization and fusion and the interommatidial bristles are partially restored.
Coexpression of cicScer\UAS.cLa and Hsap\ATX182Q.Scer\UAS, under the control of Scer\GAL4C5, results in restoration of the posterior crossvein, which is missing in flies expressing either transgene separately.